Reverse Rett LA 2024

Our 2024 gala, and your support, are more important than ever. We have moved the needle on Rett syndrome research in a big way. A few years ago, gene therapy as a potential treatment for Rett was in nascent stages. Today we have clinical trials underway and preliminary observations are promising. But to reach a cure, it’s imperative that multiple genetic medicines, beyond the current gene therapies, be aggressively pursued. That’s why the Rett Syndrome Research Trust (RSRT) has just launched a new $40 million initiative, Roadmap to Cures, with a goal to drive three more genetic approaches to clinical trials. With your help, we can profoundly change the lives of 350,000 children and adults who struggle so bravely with this devastating disorder. Thank you for your generous support.